Should Investors Give Intel Stock Another Look After Its AI Strategy Reset?

Under CEO Lip‑Bu Tan, Intel has pivoted to an AI‑inference focused strategy and flattened management, securing substantial funding and partnerships — including $8.9bn from the U.S. government, $2bn from SoftBank and a $5bn Nvidia investment — and a deal to supply chips to Apple. Financials show H1 2025 revenue of $25.5bn (essentially flat YoY) with a H1 net loss attributable to Intel of $3.7bn (vs a prior-year loss of $2bn), while Q3 revenue rose 3% YoY to $13.7bn and net income attributable to Intel was $4.1bn (versus a $16.6bn loss in 2024). The operational turnaround has driven a sharp share price recovery (from a $17.67 52‑week low to $44.02 high) and a rapidly expanded P/E multiple, prompting the view that Intel’s fundamentals look improving but the current valuation is rich — investors should await a pullback before adding exposure.

Analysis

Market structure: Intel’s pivot to inference-focused AI and the NVDA $5B strategic investment plus $8.9B U.S. funding shifts demand toward heterogeneous stacks (CPUs + accelerators + custom SoCs). Winners: NVDA (software/load on its stack), Intel (IDM capturing inference silicon spend) and OEMs like AAPL via diversified suppliers; losers: pure-play small accelerator startups and some foundry pricing power (TSM) if U.S. onshoring accelerates. The move tightens short-term demand for advanced packaging and substrates, supporting suppliers and commodity metals used in advanced fabs for 12–36 months.

Risk assessment: Tail risks include integration friction with NVDA, conditionality or clawbacks on government subsidies, and renewed product delays — any could flip sentiment and compress the stretched P/E. Timeline: days–weeks = sentiment/volatility swings; months = guidance vs. execution (next 2 quarters); years = market-share shift in inference chips (2–5 years). Hidden deps: Intel’s recovery depends on NVDA software alignment, foundry capacity for Intel’s custom nodes, and Apple volume cadence.

Trade implications: Avoid establishing large INTC longs at current premium; prefer wait-for-dip entries or structured option exposure. Direct plays: tactical long NVDA (capture software/network effects) and selective long INTC on confirmed product/earnings beats; consider buying INTC on pullback to ~$28–$32 or when trailing P/E reverts toward ~30. Use options (call spreads or protective puts) to hedge execution risk and sell tenor into near-term rallies.

Contrarian angles: Consensus prices in a smooth re-rating and flawless NVDA-Intel execution — that’s likely overdone. Historical parallels: IBM/Intel turnarounds show funding and partnerships help but take multiple earnings cycles to convert to durable margins. Unintended consequence: NVDA’s investment could create strategic tensions (roadmap control) that slow adoption and create windows for AMD/TSM to exploit.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in INTC only on a pullback to $28–$32 (≈35–45% below the Dec high); set a 12‑month target of $55 and a hard stop loss at 20% below entry to limit execution risk.
• Allocate 1–2% to NVDA via a 6‑month call spread (buy 10% ITM call, sell 25% OTM call) to capture AI-software upside while capping premium; roll or realize on any >30% move higher.
• If initiating INTC exposure, buy 9–12 month protective puts (e.g., 15% OTM) sized to cover 50% of position cost until next two quarterly reports (next 90–180 days); reduce hedges after 2 consecutive positive beats or confirmed product/customer ramps.
• Implement a pair trade: long INTC (1.5%) vs short TSM (1%) over 12 months if Intel posts two sequential quarters of revenue growth >+3% YoY and TSM reports margin contraction; unwind if INTC guidance misses or TSM beats by >3%.